Continuing GLP-1 receptor agonist medications when undergoing an endoscopic procedure appeared safe in a meta-analysis.

Drugs such as Wegovy, Ozempic, and Saxenda have quickly become household names. But are these weight loss medications right ...

GLP-1 receptor agonists are used to treat type 2 diabetes and obesity, with active ingredients including exenatide, lixisenatide, liraglutide, dulaglutide, semaglutide and tirzepatide. They work by ...

[11] The absence of severe hypoglycemia is consistent with the glucose-dependent insulinotropic mechanism of GLP-1 receptor agonists ... is the guarantor of this work and, as such, had full ...

While older medications for diabetes such as insulin and sulfonylureas predispose to weight gain, GLP-1 receptor agonists ...

For the first time in decades, the prevalence of obesity has not increased in the USA, according to the latest National Health and Nutrition Examination Survey from the US Centers for Disease Control ...

In addition, patients need to be made aware of the symptoms of hypoglycaemia that can occur in some non-diabetic patients using the drugs and what to do if it happens. Patients prescribed GLP-1 ...

Related reading: GLP-1 agonists, originally developed for diabetes management, have shown promise in aiding weight loss, ...

Glucagon-like peptide 1 receptor agonists (GLP-1 RAs ... Dicker suggested an alternative hypothesis: Does the GLP-1 RA have a direct effect on neurotransmitters and inflammation and, thus ...